Best Poster Award for Patrícia Sobral
By Glycoimmunology Laboratory, UCIBIO, NOVA FCT: "Computational approach for the discovery of small molecule inhibitors of the PD-1/PD-L1 immune checkpoint in dendritic cell-based vaccines for improved cancer immunotherapies"Conference
NOVA Health Chronic Disease and Infection: Challenges of vaccination throughout life
The NOVAhealth Chronic Disease and Infection group launches its 6th Conference.
In this meeting we will discuss the obstacles in promoting vaccination at all stages of life; the research on innovative vaccine formulations and delivery systems for long term efficacy; the development of new approaches, including digital health technologies, that target specific populations, such as the elderly and people with comorbidities; and advanced analytics of vaccination trends, and immunization gaps.
Our conference aims to fostering the presentation of novel scientific achievements and the development of cross-disciplinary collaborations. It is intended to reach a broad audience including teaching staff, researchers, students at all levels, and the general public.
It aims to present research in various formats and perspectives, allowing a wide interaction and discussion among participants and raising the society awareness on the topic.
The session will take place at the Rectorate of Universidade NOVA de Lisboa (Campolide Campus) on October 20th 2023 from 9:00 am to 1:00 pm.
Poster submission
Authors interested in presenting their research on the conference topic should submit their work (instructions and selection criteria in the call for posters).
IMPORTANT DATES
Poster submission deadline: September 29th, 2023.
Accepted abstracts will be included in the Conference Book. A “Best Poster Award” will be granted during the conference.
Any additional questions send an email to helena.soares@nms.unl.pt.
Organizing Committee
Gonçalo Figueiredo
ENSP NOVA
José Luiz Telles
ENSP NOVA
Liliana Rodrigues
IHMT NOVA
Helena Soares
NMS NOVA
Paula Videira
FCT NOVA
NOVAhealth Group
NOVA Saúde Chronic Disease and Infection Group promotes research, evidence-based knowledge and awareness to develop new effective and sustainable approaches and solutions to these problems. The group fosters academic and social discussion in order to respond to the daily challenges pose to patients, as well as, to the health systems and their professionals.
Program
Moderator: Helena Soares, FCM/NMS
09:00 – Opening Remarks: João Sàágua, Rector NOVA, Cláudio Soares, Vice-Rector NOVA
09:10 – Member of the European Parliament, Sara Cerdas
09:40 – FCT NOVA, Ana Aguiar-Ricardo
Advancing inhalation with supercritical CO2 technology
09:50 – NMS NOVA, Juliana Gonçalves
Variation of the immune response to vaccines and infection in specific life-stages
10:00 – NSPH NOVA, Vasco Ricoca Peixoto
Vacinação - ciência, transparência, cultura, redes sociais e determinantes comerciais
10:10 – FCSH NOVA, Camila Araujo Mazzini
Comunicação para a Saúde Pública: Desafios e Estratégias no Combate à hesitação vacinal e às Teorias Anti-Vacinas
10:20 – Roundtable with Talk Speakers
10:35 – Coffee Break
11:00 – ITQB NOVA, Raquel Sá Leão
Pneumococcal disease, carriage and vaccination in adulthood
11:10 – IHMT NOVA, Tiago Correia
Hesitação vacinal: entre desafios, controvérsias e soluções
11:20 – Vaccines and Antivirals Medical Lead – Pfizer, Rita Teixeira
11:30 – Roundtable with Talk Speakers
11:45 – Best Poster Award
12:00 – Concluding remarks, Secretary of State for Health Promotion, Margarida Tavares
Speakers
Sara Cerdas holds a Medical Degree by the University of Lisbon, post-graduation in Travel Medicine by the NOVA University of Lisbon, a master's degree in Public Health Sciences by the University of Umeå and is a PhD student in Public Health Sciences at Stockholm University, Sweden.
During her student and professional path, Cerdas was elected for representative positions in the global health field, like the International Federation of Medical Students Association (IFMSA), National Association of Medical Students (ANEM) and Students Association of the Faculty of Medicine of Lisbon (AEFML).
In 2019, Cerdas was elected member of the European Parliament, where she is a member of the Committee on the Environment, Public Health and Food Safety and co-chair in the European Parliament's Health Working Group.
In this capacity, she serves as her parliamentary group's shadow rapporteur on the European Commission's EU4Health program.
In 2022, she joined the Special Committee on the COVID-19 pandemic.
Ana Aguiar-Ricardo is a distinguished Chemical Engineer specializing in green chemistry and supercritical fluid technology, particularly (bio)polymer synthesis and processing. She earned her Ph.D. from NOVA School of Science and Technology (NOVA FCT), and conducted post-doctoral work at the University of Nottingham.
Ana's primary research focuses on greener chemical processing for drug delivery and (bio)separation processes.
With over 106 publications and 3 patents, she has been involved in 20 projects and led 6 funded projects. Ana supervised 15 Ph.D. theses, 4 post-doctoral fellows, and over 30 Master Theses. She received the Hovione Prize twice and was named one of 100 Women of Science by Ciência Viva.
Ana is the Head of Department of Chemistry, at NOVA FCT, and coordinates the Doctoral Program in Sustainable Chemistry. She leads the Materials for Sustainability and Wellbeing Group (MatSusWell) at LAQV REQUIMTE.
Ana is the President of EuChemS Division of Green and Sustainable Chemistry, an associate member of IUPAC Polymers Division, and member of the Interdivisional Committee on Green Chemistry for Sustainable Development (ICGCSD).
Juliana Gonçalves has a PhD in Mechanisms of Disease and Regenerative Medicine by NOVA Medical School. She was recently awarded an international grant from European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to study the molecular mechanisms of sex differential immune responses.
Juliana has 8 publications in high impact peer-reviewed journals (JCI Insight 2023, Cell Reports Medicine 2021, Plos Pathogens 2021, Frontiers in Medicine 2020). Her PhD work (2017-2021) focused on characterizing the immune response in 2 stages of women’s life: pregnancy and lactation. The work had a great impact on both scientific community and broader society. It was broadcasted 16 times by national TV and newspapers and was selected for 14 communications at national and international meetings, including a Nature Conference.
During the first COVID-19 confinement she customized an ELISA assay. During both PhD and post-doctoral period, her research has been focused on achieve sex and health equity through mechanistic biological research. Beyond being an invited reviewer for BMC Infections Diseases, Scientific Reports and Infection, she is also part of the editorial board of Frontiers in Immunology.
She is member of the Portuguese Society for Immunology since 2017 and of ESCMID since 2022.
Médico Especialista em Saúde Pública na Unidade de Saúde Pública, ACES Oeste Sul. Alumnus do European Programme for Intervention Epidemiology Training (EPIET) do ECDC em parceria com a DGS. Colabora com a DGS na área de Epidemic Intelligence. Membro da Comissão Executiva da Fundação Calouste Gulbenkian para o Projeto Boas Escolhas, Melhor Saúde. Review Editor da revista científica Frontiers in Public Health. Membro da ASPHER COVID-19 TaskForce. Membro da comissão de avaliação da Agência de Avaliação e Acreditação do Ensino Superior (A3ES) para os cursos de medicina. Docente convidado de Epidemiologia e investigador do Centro de Investigação em Saúde Pública da Escola Nacional de Saúde Pública.
Trabalho recente e áreas de interesse: identificação de factores de associados a outcomes de saúde; vigilância epidemiológica e epidemic intelligence; impacto, efetividade e segurança de intervenções; prevenção e controlo de doenças infecciosas, saúde global e pandemias (COVID-19), impacto de políticas de saúde, qualidade em serviços de saúde, acesso e integração de dados, avaliação económica em saúde, cultura e Saúde Pública, redes sociais e Saúde Pública,
alterações climáticas e Saúde Pública.
É mestranda em Ciências da Comunicação na vertente em Comunicação Estratégica pela Faculdade de Ciências Sociais e Humanas da Universidade NOVA de Lisboa (FCSH UNL) e trabalha num projeto de investigação sobre estratégias para melhorar a comunicação relativamente à vacinação.
É consultora de Marketing e Comunicação para a empresa norte-americana Ingredion, suportando a estratégia dos negócios de Farmacêuticos & Nutracêuticos da companhia.
Com mais de 5 anos de experiência no mercado de comunicação corporativa, atuou em indústrias multinacionais de bens de produção e química para diversos segmentos.
Raquel Sá-Leão is Principal Investigator and Head of the Laboratory of Molecular Microbiology of Human Pathogens at ITQB NOVA. She is also Vice-Dean at the same institution.
Raquel has a long stand interest on pneumococcal ecology. Current interests include investigating how the use of vaccines and antibiotics is shaping the pneumococcal population; how intra-species interactions affect pneumococcal colonization; and the dynamics of pneumococcal colonization in adulthood.
To support these studies Raquel is actively engaged in the development and validation of accurate highly sensitive methods to detect pneumococcal carriage in polymicrobial samples.
Tiago Correia é doutorado em Sociologia pelo Instituto Universitário de Lisboa – especialização em saúde e medicina –, e obteve dois pós-doutoramentos em Saúde Pública pela Universidade de Montreal e McGill University.
Ingressou no Instituto de Higiene e Medicina Tropical da Universidade NOVA de Lisboa (IHMT-NOVA) como Professor Associado na Unidade de Saúde Pública Global, onde obteve o título de agregado em Políticas de Saúde e Desenvolvimento.
Representa o IHMT na Associação Internacional de Institutos Nacionais de Saúde Pública (IANPHI), na Associação de Escolas de Saúde Pública da Região Europeia (ASPHER) e na Associação Europeia de Gestão da Saúde (EHMA). É editor-chefe do International Journal of Health Planning and Management. Coordena projetos europeus na área da hesitação vacinal.
-
Médica de Saúde Pública
-
Pós graduação em Gestão de Unidades de Saúde no ISCTE
-
Doutoranda em Saúde Pública na ENSP
-
Medical Affairs Scientist na Pfizer na área “Vaccines and Antivirals”
Margarida Tavares is an infectious diseases doctor, graduated from the University of Porto Medical School (Portugal) and completed a Master in Public Health at École Pasteur-CNAM de Santé Publique in Paris (France).
She worked in the Infectious Diseases Department at University Hospital Centre of São João (Porto), where she was medical director between 2010 and 2015.
Additionally, she was director of the national programme for STIs and HIV (2021-2022), member of national task force to respond to mpox virus (2022) and part of several national technical groups related to public health emergencies (flu, ebola, COVID-19). Since September 2022, she is Secretary of State of Health Promotion.